Clinical Trial Update: A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing guselkumab to fumaric acid esters in moderate to severe plaque psoriasis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen-Cilag G.m.b.H | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2019-02-15